Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Nov;90(11):2793-2801.
doi: 10.1111/bcp.16168. Epub 2024 Jul 6.

Discovering interactions in polypharmacy: Impact of metamizole on the metabolism of quetiapine

Affiliations
Free article

Discovering interactions in polypharmacy: Impact of metamizole on the metabolism of quetiapine

Fabian Watermeyer et al. Br J Clin Pharmacol. 2024 Nov.
Free article

Abstract

Aims: Metamizole is quite an old drug with analgesic, antipyretic and spasmolytic properties. Recent findings have shown that it may induce several cytochrome P450 (CYP) enzymes, especially CYP3A4 and CYP2B6. The clinical relevance of these properties is uncertain. We aimed to unravel potential pharmacokinetic interactions between metamizole and the CYP3A4 substrate quetiapine.

Methods: Plasma concentrations of quetiapine from a large therapeutic drug monitoring database were analysed. Two groups of 33 patients, either receiving quetiapine as a monotherapy (without CYP modulating comedications) or with concomitantly applied metamizole, were compared addressing a potential impact of metamizole on the metabolism of quetiapine being reflected in differences of plasma concentrations of quetiapine and dose-adjusted plasma concentrations.

Results: Patients comedicated with metamizole showed >50% lower plasma concentrations of quetiapine (median 45.2 ng/mL, Q1 = 15.5; Q3 = 90.5 vs. 92.0 ng/mL, Q1 = 52.3; Q3 = 203.8, P = .003). The dose-adjusted plasma concentrations were 69% lower in the comedication group (P = .001). Subgroup analyses did not suggest a dose dependency of the metamizole effect or an influence of quetiapine formulation (immediate vs. extended release). Finally, the comedication group exhibited a significantly higher proportion of patients whose quetiapine concentrations were below the therapeutic reference range (78.8% in the metamizole group vs. 54.4% in the control group, P = .037) indicating therapeutically insufficient drug concentrations.

Conclusion: The combination of metamizole and quetiapine leads to significantly lower drug concentrations of quetiapine, probably via an induction of CYP3A4. Clinicians must consider the risk of adverse drug reactions, especially treatment failure under quetiapine when adding metamizole.

Keywords: cytochrome; interaction; metamizole; pharmacokinetics; quetiapine; therapeutic drug monitoring.

PubMed Disclaimer

References

REFERENCES

    1. Maher AR, Maglione M, Bagley S, et al. Efficacy and comparative effectiveness of atypical antipsychotic medications for off‐label uses in adults: a systematic review and meta‐analysis. JAMA. 2011;306(12):1359‐1369. doi:10.1001/jama.2011.1360
    1. Jalil J, Nazarian P, von Walter HF. Polypharmacy in treatment of behavioral issues in dementia‐use of atypical antipsychotics. Clin Geriatr Med. 2022;38(4):641‐652. doi:10.1016/j.cger.2022.05.006
    1. Schwalbe W‐DL U.: Arzneiverordnungs—Report 2020. Aktuelle Daten, Kosten, Trends und Kommentare, Springer‐Verlag GmbH; 2020.
    1. Figueroa C, Brecher M, Hamer‐Maansson JE, Winter H. Pharmacokinetic profiles of extended release quetiapine fumarate compared with quetiapine immediate release. Prog Neuropsychopharmacol Biol Psychiatry. 2009;33(2):199‐204. doi:10.1016/j.pnpbp.2008.09.026
    1. Oruch R, Pryme I, Fasmer O, Lund A. Quetiapine: an objective evaluation of pharmacology, clinical uses and intoxication. EC Pharmacol Toxicol. 2020;8:1‐26.

MeSH terms

LinkOut - more resources